You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
26 July 2024 - Biopharmaceutical company CStone Pharmaceuticals (HKEX:2616) on Friday announced European Commission approval of sugemalimab (Cejemly) in combination with platinum-based chemotherapy for first-line treatment of non-small cell lung canc...
26 July 2024 - Presage Biosciences, a US-based biotechnology company that directly measures activity of oncology drugs within human tumours, announced on Thursday that it has commenced Phase 0 dosing of the first cancer patient with Poland-based Pure...
25 July 2024 - Biopharmaceutical company Ipsen (Euronext Paris:IPN) (ADR:IPSEY) announced on Thursday that it has licensed ex-US rights to Day One Biopharmaceuticals' (Nasdaq:DAWN) tovorafenib for paediatric low-grade glioma (pLGG), the most com...
25 July 2024 - US-based M8 Pharmaceuticals, an Acino company, announced on Wednesday that it has entered into an exclusive licensing and distribution agreement with South Korea-based LG Chem Ltd.The agreement has been signed for M8 to market, commerc...
24 July 2024 - HIV research company Gilead Sciences Inc (Nasdaq: GILD) on Wednesday presented full efficacy and safety results from its Phase 3 PURPOSE 1 trial at the 25th International AIDS Conference (AIDS 2024).Lenacapavir, a twice-yearly injectab...
24 July 2024 - California-based biotechnology company Anixa Biosciences Inc (NASDAQ: ANIX) announced on Tuesday that the US Food and Drug Administration (FDA) has granted approval to the company's collaborator, Moffitt Cancer Center, for an indi...
24 July 2024 - US kidney care speciailst Evergreen Nephrology announced on Tuesday the appointment of David Young to its board of directors.Young has served in leadership roles such as CEO of GenesisCare, president & CEO of Physicians Endoscopy I...